Literature DB >> 3004901

Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells.

N Kurihara, S Ishizuka, M Kiyoki, Y Haketa, K Ikeda, M Kumegawa.   

Abstract

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] was examined for a possible stimulative effect on osteoblastic MC3T3-E1 cells. During the early period of culture, 1,25-(OH)2D3 had a stimulative effect. During the growth phase, however, the steroid had little effect on either the protein or DNA content of the cultures. 1,25-(OH)2D3 increased bone-liver-kidney-type alkaline phosphatase activity in a dose-related manner up to a concentration of 5 pg/ml; the increase was 2.2-fold over the control value. Studies on the effect of actinomycin D or cycloheximide treatment indicated that the vitamin may enhance de novo synthesis of ALP. The steroid also stimulated type I collagen production dose dependently via an increase in collagen synthesis rather than by inhibition of collagen degradation. MC3T3-E1 cells have a specific receptor for 1,25-(OH)2D3 which has a dissociation constant of 4.17 X 10(-11) M and a sedimentation coefficient of 3.67S. The receptor concentration varied with the period of culture, being higher during the growth phase and lower at confluence, but its affinity did not change. The results indicate that 1,25-(OH)2D3 has a direct specific anabolic effect on osteoblastic cells in vitro during the growth phase and that this effect is related to receptor concentration.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004901     DOI: 10.1210/endo-118-3-940

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Isolation and characterization of proteoglycans synthesized by mouse osteoblastic cells in culture during the mineralization process.

Authors:  Y Takeuchi; T Matsumoto; E Ogata; Y Shishiba
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

2.  17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.

Authors:  T K Gray; T C Flynn; K M Gray; L M Nabell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

3.  Stimulation by bone sialoprotein of calcification in osteoblast-like MC3T3-E1 cells.

Authors:  H Y Zhou; H Takita; R Fujisawa; M Mizuno; Y Kuboki
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

4.  Prevention of bone loss in postmenopausal and senile osteoporosis with vitamin D analogues.

Authors:  J C Gallagher
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

5.  Mechanisms of cellular recruitment in aseptic loosening of prosthetic joint implants.

Authors:  S M Horowitz; M A Purdon
Journal:  Calcif Tissue Int       Date:  1995-10       Impact factor: 4.333

6.  Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy.

Authors:  E Takeda; I Yokota; I Kawakami; T Hashimoto; Y Kuroda; S Arase
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

7.  Functional activation of the egr-1 (early growth response-1) gene by hydrogen peroxide.

Authors:  K Nose; M Ohba
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

8.  The interaction of the macrophage and the osteoblast in the pathophysiology of aseptic loosening of joint replacements.

Authors:  S M Horowitz; B P Rapuano; J M Lane; A H Burstein
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

9.  Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta-glycerophosphate and ascorbic acid.

Authors:  D D Dean; Z Schwartz; L Bonewald; O E Muniz; S Morales; R Gomez; B P Brooks; M Qiao; D S Howell; B D Boyan
Journal:  Calcif Tissue Int       Date:  1994-05       Impact factor: 4.333

10.  Constitutive expression of calreticulin in osteoblasts inhibits mineralization.

Authors:  R St-Arnaud; J Prud'homme; C Leung-Hagesteijn; S Dedhar
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.